Quantitative PCR Analysis of Gut Disease-Discriminatory Phyla for Determining Shrimp Disease Incidence

Weina Yu1,2, Jinxuan Cao1, Wenfang Dai1,2

  • 1School of Marine Sciences, Ningbo University, Ningbo, China.

Insights

We developed a quantitative PCR (qPCR) method to detect gut microbes linked to shrimp disease. This technique accurately predicts disease incidence and onset, offering a practical tool for aquaculture health management.

Area of Science:

  • Aquatic animal health
  • Microbiome research
  • Molecular diagnostics

Background:

  • Gut microbial signatures are linked to host health.
  • Current high-throughput sequencing (HTS) methods for microbial analysis are costly and time-consuming, limiting routine aquaculture monitoring.

Purpose of the Study:

  • To establish a practical, quantitative PCR (qPCR)-based approach for detecting gut disease-discriminatory phyla in shrimp.
  • To enable accurate determination of shrimp disease incidence and onset using microbial signatures.

Main Methods:

  • Developed a qPCR assay targeting disease-discriminatory gut phyla in shrimp, differentiating them from age-discriminatory phyla.
  • Validated qPCR results against Illumina sequencing, showing high consistency (r = 0.946).
  • Utilized microbial profiles and weight coefficients to predict future disease outcomes.

Main Results:

  • The qPCR approach achieved 93.2% overall diagnostic accuracy for shrimp disease and 70% accuracy at the early onset stage.
  • Relative abundances of 10 key phyla measured by qPCR strongly correlated with HTS data.
  • The method accurately estimated future disease incidence based on microbial profiles.

Conclusions:

  • A validated qPCR technique can quantitatively determine shrimp disease incidence and onset.
  • This method offers a cost-effective and efficient alternative to HTS for routine aquaculture health management.
  • The study provides a valuable tool for improving shrimp health and addressing economic losses in aquaculture.

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
2.4K
Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
1.9K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.2K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
966
Principles of Disease Surveillance01:26

Principles of Disease Surveillance

Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
563